Actively Recruiting
Phase 1 Study of Radiation Before Chemoimmunotherapy and Surgery for Borderline Resectable Non-Small Cell Lung Cancer
Led by University of Maryland, Baltimore · Updated on 2026-05-06
18
Participants Needed
4
Research Sites
104 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating if adding a specific type of radiation called stereotactic body radiation therapy SBRT before chemoimmunotherapy and surgery is effective for people with borderline resectable non-small cell lung cancer NSCLC. This study focuses on patients who may be able to have surgery and aims to assess the tolerability and effects of combining these treatments. The research is sponsored by the University of Maryland, Baltimore.
CONDITIONS
Brief Title
A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer
Research Team
M
Matthew Ferris, MD
C
Caitlin Eggleston, MPH
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
